Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for REM sleep behavior disorder associated with Parkinson's disease
RBR-5fwhf7Phase 2Recruiting
- Sponsor
- Universidade de São Paulo
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of cannabidiol in REM sleep behavior disorder (RBD) (2 arms), sponsored by Universidade de São Paulo. Started Aug 2017; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
REM sleep behavior disorder (RBD)
Beyond the preview
Go deeper on RBR-5fwhf7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5fwhf7.